Morgan Stanley Starts Avalyn Pharma (AVLN) at Overweight May 26, 2026 12:54AM
Jefferies Starts Avalyn Pharma (AVLN) at Buy May 25, 2026 10:31AM
Guggenheim Starts Avalyn Pharma (AVLN) at Buy May 25, 2026 10:13AM
Avalyn to present 4-year data on inhaled pirfenidone at EULAR 2026 May 21, 2026 08:03AM
Avalyn Pharma (AVLN) files for 16.67M share IPO at $16-$18/sh Apr 29, 2026 09:36AM


Apr 8, 2026 04:05PM Avalyn Pharma files for Nasdaq IPO